Table: Cosmos Pharmaceutical - 6-MTH group results

Cosmos Pharmaceutical

13/01/2026 06:30

Jan 13 (Reuters)- 
             Cosmos Pharmaceutical Corp. 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                 6 months ended      6 months ended       Year to 
                Nov 30, 2025        Nov 30, 2024     May 31, 2026 
                   LATEST             YEAR-AGO          LATEST    
                   RESULTS             RESULTS         FORECAST   
  Sales            537.18              505.94          1.06 trln  
                 (+6.2 pct)          (+6.2 pct)       (+4.5 pct)  
  Operating         20.68               20.34            40.50    
                 (+1.6 pct)          (+28.5 pct)      (+0.2 pct)  
  Recurring         21.93               21.78            43.20    
                 (+0.7 pct)          (+25.5 pct)      (+0.1 pct)  
  Net               14.65               14.43            31.00    
                 (+1.5 pct)          (+24.5 pct)      (+0.1 pct)  
  EPS            184.83 yen          182.05 yen       391.13 yen  
  Ann Div                             70.00 yen        75.00 yen  
  -Q2 div         37.50 yen           32.50 yen                   
  -Q4 div                             37.50 yen        37.50 yen  
  
  NOTE - Cosmos Pharmaceutical Corp.. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=3349.T